PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1355652
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1355652
Global Central Fill Pharmacy Automation Market is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period 2023-2030. A "central fill pharmacy" is a pharmacy authorized by its state of residence to prepare controlled substance orders based on valid prescriptions received from a registered retail pharmacy. The central fill pharmacy then sends the labeled and filled prescription back to the retail pharmacy, which delivers it to the end consumer. The market is driven by key factors such as surging incidence of chronic diseases and increasing demand for specialty drug prescriptions.
According to Statista, in Portugal, over 80% of those with chronic diseases or long-term health issues (those that have lasted or are anticipated to persist for at least six months) in 2021 had no formal education. According to statistics, as one's level of education rises, the proportion of persons who have long-term health issues or chronic diseases decreases. Around 23.7 million individuals in Italy had at least one chronic illness in 2021. The number of people who experienced each of the most prevalent chronic diseases in the same year. Nearly 11.2 million Italians had hypertension, the most prevalent illness, and 8.8 million of them had osteoarthritis or arthritis. Moreover, rising government support for enhancement of healthcare facilities and increasing number of pharmaceutical companies create lucrative opportunities for the market growth. However, lack of Skilled Healthcare Professionals to Operate machines stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Central Fill Pharmacy Automation Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market with largest market share owing to focus of government organizations on the enhancement of healthcare facilities. However, Asia Pacific is expected to be the fastest growing region due to increasing unintentional and intentional injuries in geriatric population demands the fastest and accurate supply of medication.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable